Since Brexit, placing pet grooming and care products on the Great Britain market follows its own rulebook, and treating it as a copy of the EU file is the most common and most expensive mistake exporters make. The differences are not philosophical. They sit in substance registration, hazard communication, the named person who holds the file and the notification step for cosmetic-type products. This guide maps where UK requirements diverge from the EU so you can plan one dossier structure that branches per market, rather than building two from scratch.
What Actually Changed
Great Britain, meaning England, Scotland and Wales, is now a separate regulatory jurisdiction from the European Union. EU law no longer applies directly, and a product placed on a GB shelf is placed under GB law even when the formula, the factory and the brand are European. Northern Ireland is a different case again: for many goods it continues to apply EU rules under the Windsor Framework, so a launch described as UK-wide can be two regulatory launches sharing one warehouse.
What did not change is the science underneath. Hazard classes, exposure logic, safety assessment principles and most substance restrictions remain recognisably aligned, which is why a single technical dossier still works as the core document. What cannot be shared is the legal wrapper around it: the named responsible entity, the classification decision, the label artwork and any notification. The efficient model is one technical core with two market shells, versioned separately and reviewed on separate calendars.
UK REACH: Substance Coverage Is the Real Question
UK REACH operates independently of EU REACH. A substance registered in the EU is not automatically covered in Great Britain, and the registration obligation in GB falls on manufacturers and importers established there, with arrangements available for appointing a GB-based representative. For a European or Asian brand selling into GB, that means the practical question is not whether the formula is compliant in principle, but whether every substance in it has current GB coverage behind it.
That is a supplier-management job rather than a labelling job. Ask each raw material supplier for a written statement of GB coverage, check the substance against the GB candidate list for substances of very high concern and the GB restrictions, and note the date the position was confirmed. A supplier who has not maintained GB registrations can leave you with a compliant EU file and an unsellable pallet at the border. Substitution is often slower and more expensive than the registration gap itself, so check early, ideally before the formula is frozen.
The GB safety data sheet follows from this. It needs GB classification and GB supplier details rather than a relabelled EU document, and it should be dated and version controlled so that a retailer, a distributor or a customs broker is looking at the same revision you are.
GB CLP: Classification, Labels and Safety Data Sheets
Hazard communication in Great Britain follows GB CLP, which has diverged from EU CLP over time. Amendments adopted in the EU, including new hazard classes and updates to technical entries, do not automatically apply in GB, and GB changes do not flow back into the EU. The consequence is simple and often overlooked: an EU-compliant label is not necessarily GB-compliant, and the reverse is also true. Reading the EU classification rules, for example through ECHA's CLP guidance, shows how much of the underlying logic is shared even where the legal instruments are not.
For pet care products the review usually touches surfactant-containing mixtures, fragrance allergens, preservatives and any product carrying a hazard classification. Even where a product is not classified as hazardous, other labelling rules may still require ingredient disclosure or warnings. Budget the GB review as its own line item with its own calendar rather than as a proofread of the EU artwork, because a classification decision that changes a pictogram also changes the carton, the case mark and sometimes the transport documents.
The UK Responsible Person
Non-UK brands need a UK Responsible Person established in Great Britain to act as the regulatory contact and hold the product information file. The role mirrors the EU responsible person: a named entity with a GB address that appears on the label, answers authority queries and keeps the technical documentation available. Appointing one early keeps the file, the notification and the artwork aligned, and it gives customs and retailers a local point of contact when a question arises.
It is worth being precise about what the role is not. A UK Responsible Person is not a distributor of record, a marketing partner or a substitute for your own quality agreement with the manufacturer. Write the scope down: who maintains the file, who approves label changes, who responds to an enquiry within the required time, and who pays for additional testing when a classification changes. The most common failure in this area is not a missing appointment but an appointment nobody briefed.
EU and GB Obligations Compared
The table compares the two regimes at the level a brand actually plans against. It is a planning aid, not legal advice: confirm each item against the current published guidance before you commit artwork or a first shipment, because both regimes continue to change.
| Obligation | European Union | Great Britain | Practical impact |
|---|---|---|---|
| Chemical registration | EU REACH, administered by ECHA | UK REACH, administered by the GB regulator | Substance coverage must be confirmed separately; EU registration does not carry over |
| Hazard classification and labelling | EU CLP | GB CLP | Classification, pictograms and statements reviewed against the GB version |
| Regulatory contact | EU responsible person or importer | UK Responsible Person established in GB | Named entity with a GB address holds the file and answers queries |
| Cosmetic-type notification | EU notification portal for cosmetic products | Separate GB notification route | Second notification, second fee, second artwork version |
| Borderline claims | EU rules on biocides and veterinary medicines | GB equivalents administered by the GB regulator | A disinfecting or treating claim changes the entire regulatory route |
Source: Puyan Pet regulatory planning framework, compiled from EU and GB published guidance; verify current requirements before filing.
Notified Products and Borderline Claims
Most pet grooming products are not registered in advance in either market, which makes the claims review the real gate. A cleaning product, a cosmetic-type leave-on and a disinfectant can be the same liquid in three bottles, and each carries a different obligation. The table sets out the routes a single formula can take depending on what the label says.
Two practical consequences follow. First, decide the claim before the artwork, because a word like sanitises moves the product into a regime where the timeline is measured in months of efficacy work rather than weeks of labelling. Second, keep the evidence for the chosen claim in the same file as the label version it supports, so that a retailer questionnaire or an authority enquiry can be answered from one document set rather than reconstructed from emails.
| What the label claims | Regulatory route | What it costs you |
|---|---|---|
| Cleans, deodorises, conditions | General product safety plus cosmetic-type obligations where applicable | Safety assessment, labelling review, notification where required |
| Kills bacteria, viruses or fungi | Biocidal products regime | Authorisation, efficacy data, much longer timeline |
| Treats or prevents a condition | Veterinary medicine regime | Marketing authorisation route, usually not viable for grooming |
| Reduces allergens or is hypoallergenic | General claims law with substantiation | Defined test method and a claims file before artwork |
Source: Puyan Pet claims classification notes; classification depends on presentation and intended use, not on the formula alone.
Deadlines and Planning Assumptions
UK REACH transitional arrangements have been revised more than once, and the current published dates should be treated as planning assumptions rather than fixed commitments. That is not a reason to delay; it is a reason to build the plan so that a date change moves a milestone rather than invalidating the whole launch. Keep the registration status of each substance in a single register with a last-verified date, and review it on a fixed cadence.
Two habits prevent most deadline surprises. The first is assigning one named owner for regulatory watch, rather than distributing it across a product team that reads updates when a launch is already late. The second is dating every document in the dossier, because a safety data sheet, a classification decision and a label artwork that were valid in different years are a common audit finding and an easy one to avoid.
- Substance register with GB coverage status and last-verified date
- GB classification decision documented separately from the EU decision
- UK Responsible Person appointed and briefed before artwork is finalised
- Notification or filing completed before the first shipment, not before the first reorder
- One owner for regulatory watch, with a fixed review cadence
One Dossier, Several Markets
The commercial argument for a modular dossier is straightforward. The technical core, meaning the formula, the safety assessment, the stability data, the challenge test and the manufacturing records, is largely market-neutral. The market shells, meaning classification, labelling, notification, responsible entity and language, change per territory. If you structure the file that way from the start, adding a market becomes a review exercise rather than a rebuild.
Our EU compliance guide and US market entry guide cover the other two pillars of a multi-market plan, and the same branching logic applies to each. If you are preparing a GB launch alongside an EU one, send us your product list and we will map which documents can be shared and which have to be produced per market, together with the timeline each one needs.
Frequently Asked Questions
Is an EU-compliant label acceptable in Great Britain?
Not automatically. GB CLP has diverged from EU CLP, so hazard classes, statements and supplemental information can differ, and the supplier details must reflect a GB entity where required. Treat the GB label as a separate artwork version with its own approval record. The cost of a review is small compared with the cost of a print run that cannot be sold into the market it was designed for.
Does an EU REACH registration cover the GB market?
No. UK REACH is a separate regime, and substances registered in the EU are not automatically covered in Great Britain. The registration obligation falls on GB manufacturers and importers, with arrangements available for appointing a GB-based representative. Practically, ask every raw material supplier for a written GB coverage statement and keep the date it was confirmed, because coverage can lapse unnoticed between orders.
Who needs a UK Responsible Person?
A brand without an establishment in Great Britain generally needs one to act as the regulatory contact and hold the product information file, in the same way an EU responsible person works in the European Union. The person must be established in GB and appears on the label with a GB address. Appoint before artwork is finalised, because changing that address later means a reprint across every SKU.
Does Northern Ireland follow the same rules as Great Britain?
No. Under the Windsor Framework, Northern Ireland continues to apply EU rules for many goods, so it sits closer to the EU regime than to GB. A shipment to Belfast and a shipment to Manchester can require different labels and different documentation from the same production batch. Plan Northern Ireland as its own line in the market plan rather than as part of a single UK launch.
How long does GB compliance add to a launch?
It depends on whether the classification changes and whether any substance lacks GB coverage. A straightforward relabel with an existing UK Responsible Person can be handled inside a normal artwork cycle. A substance with no GB registration can add months, because it depends on a supplier or a registration decision outside your control. Sequence the substance check first, since it is the item most likely to move the launch date.
Do we need a separate safety data sheet for GB?
Yes, in practice. The GB sheet must reflect GB classification and GB supplier details, and it should be version controlled and dated so distributors, retailers and customs see the current revision. Many brands keep one technical source and generate two formatted outputs from it. That approach keeps the chemistry consistent while allowing the legal wrapper, including the supplier block and the classification decision, to differ per market.
Conclusion
UK compliance is not EU compliance with a different flag on the carton. Confirm GB coverage for every substance, produce a GB classification and label rather than a relabelled EU document, and appoint a UK Responsible Person who has actually been briefed on the file. Then reuse the dossier logic across markets by separating the technical core from the legal shell. That structure turns market expansion into a review exercise, keeps the science consistent, and stops a single missing registration from stranding a pallet at the border while the launch calendar runs on. The work is unglamorous and mostly documentary, and it is also the cheapest insurance a brand can buy against a launch that cannot ship.
